TScan Therapeutics Files Definitive Proxy Statement
Ticker: TCRX · Form: DEF 14A · Filed: May 14, 2025 · CIK: 1783328
| Field | Detail |
|---|---|
| Company | Tscan Therapeutics, Inc. (TCRX) |
| Form Type | DEF 14A |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, sec-filing
Related Tickers: TSCN
TL;DR
TSCN proxy statement filed. Shareholders vote on company matters.
AI Summary
TScan Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on May 14, 2025, for its fiscal year ending December 31, 2024. The filing pertains to the company's annual meeting and related corporate governance matters. The company is based in Waltham, MA, and operates in the biological products sector.
Why It Matters
This filing provides shareholders with crucial information regarding the company's governance, executive compensation, and voting matters ahead of their annual meeting, enabling informed participation.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) that does not contain new financial results or significant operational changes.
Key Players & Entities
- TScan Therapeutics, Inc. (company) — Registrant
- 0001783328 (company) — Central Index Key
- Waltham, MA (location) — Company Headquarters
- May 14, 2025 (date) — Filing Date
- December 31, 2024 (date) — Fiscal Year End
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes on important corporate matters, such as the election of directors, executive compensation, and other proposals, typically in advance of an annual meeting.
When did TScan Therapeutics file its definitive proxy statement?
TScan Therapeutics filed its definitive proxy statement on May 14, 2025.
What is TScan Therapeutics, Inc.'s fiscal year end?
TScan Therapeutics, Inc.'s fiscal year ends on December 31.
Where is TScan Therapeutics, Inc. located?
TScan Therapeutics, Inc. is located at 880 Winter Street, Waltham, MA 02451.
What is the SEC file number for TScan Therapeutics, Inc.?
The SEC file number for TScan Therapeutics, Inc. is 001-40603.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 14, 2025 regarding TScan Therapeutics, Inc. (TCRX).